search
Back to results

Robotic Mediated Therapy for Pseudoparalysis in Massive Rotator Cuff Tear

Primary Purpose

Pseudoparalysis Due to Massive Rotator Cuff Tear

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Robotic mediated therapy with MJS (multi joint system) Tecnobody
Sponsored by
Schulthess Klinik
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pseudoparalysis Due to Massive Rotator Cuff Tear focused on measuring Massive rotator cuff tear, Pseudoparalysis, Robotic mediated therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Active flexion <45°
  • Massive, irreparable, atraumatic RC tear at least two tendons
  • Almost full passive ROM glenohumeral (140-180°)
  • Fatty infiltration of the muscle Goutallier grade III or IV
  • Persistent loss of active ROM after injection
  • Ability to speak and understand German or English

Exclusion Criteria:

  • Neurological disease
  • Clinical diagnosis of rheumatoid arthritis, glenohumeral osteoarthritis, periarthritis and necrosis
  • RC repair in the previous two years
  • Acute fracture
  • Acute traumatic RC tear
  • Capsular shoulder stiffness

Sites / Locations

  • Schulthess Klinik

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Robotic mediated therapy

Arm Description

Robotic mediated therapy with MJS (multi joint system) Tecnobody

Outcomes

Primary Outcome Measures

Patient satisfaction
Numeric rating scale (NRS) from 0=not at all satisfied to 10=fully satisfied
Treatment compliance
Adherence of training in % of the 18 planned sessions
Treatment tolerance
Pain Level during and after Training NRS 0=no pain to 10=maximum pain

Secondary Outcome Measures

Shoulder range of motion
Active ROM shoulder flexion and abduction
OSS
Oxford shoulder score (0-48)
SSV
Subjective shoulder value (0-100%)
Pain NRS
Pain during ADL (activity of daily living): NRS 0 = no pain to 10 = maximum pain
EQ-5D utilities
Quality of life (EuroQol EQ-5D-5L)
AE
Adverse events

Full Information

First Posted
April 3, 2019
Last Updated
October 20, 2020
Sponsor
Schulthess Klinik
search

1. Study Identification

Unique Protocol Identification Number
NCT03905499
Brief Title
Robotic Mediated Therapy for Pseudoparalysis in Massive Rotator Cuff Tear
Official Title
Can Robotic Mediated Therapy Affect Pseudoparalysis in Patients Treated for Massive Rotator Cuff Tear? A Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
June 1, 2019 (Actual)
Primary Completion Date
March 31, 2020 (Actual)
Study Completion Date
June 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Schulthess Klinik

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objective of this study is to evaluate the feasibility of a robotic mediated therapy in a clinical setting and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis. Ten patients with clinical signs of pseudoparalysis will be recruited through doctors and physical therapists based on eligibility criteria. Enrolled patients will conduct a specific trainings program with the MJS Tecnobody (Multi Joint System 614P Tecnobody Srl, IT) three times a week over a period of six weeks. Feasibility assessment will be performed six and twelve weeks after baseline and secondary outcomes (Oxford shoulder score, subjective shoulder value, pain level during activity of daily living, active shoulder flexion and abduction and quality of life EQ-5D-5L)will be assessed at baseline, six and twelve weeks after the beginning. Statistical analysis will be descriptive and secondary analysis will be analysed with a univariate paired non-parametric analysis.
Detailed Description
Rotator cuff tears are a common disorder in chronic shoulder pain. Common Complaints are pain, loss of range of motion and loss of strength. 20% of all tears are massive, in re-ruptures even 80%, with at least two tendons involved and this could lead to pseudoparalysis. The recommendation for the initial treatment is non-operative with physical therapy although people often receive a shoulder endoprosthesis. Robotic mediated therapy in patients with neurological disorders is already common, in rotator cuff tears it is less frequent and evidence is rare though. Therefore, the primary objective of this study is to evaluate the feasibility of a robotic mediated therapy in a clinical setting, in terms of satisfaction, compliance and tolerance, and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis. Ten patients with clinical signs of pseudoparalysis will be recruited in the Schulthess clinic in Zurich through doctors and physical therapists of the shoulder and elbow surgery department based on eligibility criteria. Eligible patient will be enclosed after signing the informed consent. The patients will conduct a specific trainings program with the MJS Tecnobody (Multi Joint System 614P Tecnobody Srl, IT) three times a week over a period of six weeks. The training is guided by a specialised physical therapist and the trainings program is developed by physical therapists and doctors of the Schulthess clinic based on current literature. Feasibility assessment will be performed six and twelve weeks after baseline and secondary outcomes (Oxford shoulder score, subjective shoulder value, pain level during activity of daily living, active shoulder flexion and abduction and quality of life EQ-5D-5L) will be assessed at baseline, six and twelve weeks after the beginning. Primary analysis will be descriptive and secondary analysis will be analysed with a univariate paired non-parametric analysis. All statistical tests will be two-sided and the level of significance will be set at p < 0.05. All analyses will be exploratory. The author expects, based on recent literature, that patients will accept well the MJS treatment and show high compliance and satisfaction, in particular if it is associated with improved active range of motion, shoulder function and quality of life at final follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pseudoparalysis Due to Massive Rotator Cuff Tear
Keywords
Massive rotator cuff tear, Pseudoparalysis, Robotic mediated therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Robotic mediated therapy
Arm Type
Experimental
Arm Description
Robotic mediated therapy with MJS (multi joint system) Tecnobody
Intervention Type
Device
Intervention Name(s)
Robotic mediated therapy with MJS (multi joint system) Tecnobody
Intervention Description
The intervention will include 18 30-minutes trainings evenly distributed over a time period of 6 weeks and will be administered by the same two physiotherapists at the Schulthess clinic based on the standardized protocol
Primary Outcome Measure Information:
Title
Patient satisfaction
Description
Numeric rating scale (NRS) from 0=not at all satisfied to 10=fully satisfied
Time Frame
3 months
Title
Treatment compliance
Description
Adherence of training in % of the 18 planned sessions
Time Frame
6 weeks
Title
Treatment tolerance
Description
Pain Level during and after Training NRS 0=no pain to 10=maximum pain
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Shoulder range of motion
Description
Active ROM shoulder flexion and abduction
Time Frame
3 months
Title
OSS
Description
Oxford shoulder score (0-48)
Time Frame
3 months
Title
SSV
Description
Subjective shoulder value (0-100%)
Time Frame
3 months
Title
Pain NRS
Description
Pain during ADL (activity of daily living): NRS 0 = no pain to 10 = maximum pain
Time Frame
3 months
Title
EQ-5D utilities
Description
Quality of life (EuroQol EQ-5D-5L)
Time Frame
3 months
Title
AE
Description
Adverse events
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Active flexion <45° Massive, irreparable, atraumatic RC tear at least two tendons Almost full passive ROM glenohumeral (140-180°) Fatty infiltration of the muscle Goutallier grade III or IV Persistent loss of active ROM after injection Ability to speak and understand German or English Exclusion Criteria: Neurological disease Clinical diagnosis of rheumatoid arthritis, glenohumeral osteoarthritis, periarthritis and necrosis RC repair in the previous two years Acute fracture Acute traumatic RC tear Capsular shoulder stiffness
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Markus Scheibel, Dr
Organizational Affiliation
Schulthess Klinik
Official's Role
Principal Investigator
Facility Information:
Facility Name
Schulthess Klinik
City
Zürich
State/Province
ZH
ZIP/Postal Code
8008
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Robotic Mediated Therapy for Pseudoparalysis in Massive Rotator Cuff Tear

We'll reach out to this number within 24 hrs